Literature DB >> 20433678

Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience.

Gaetano Restivo Pantalone, Disma Renda, Franco Valenza, Fabio D'Amato, Angela Vitrano, Filippo Cassarà, Paolo Rigano, Veronica Di Salvo, Antonino Giangreco, Elvira Bevacqua, Aurelio Maggio.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20433678     DOI： 10.1111/j.1365-2141.2010.08180.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  13 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Recent advances in β-thalassemias.

Authors:  Antonio Cao; Paolo Moi; Renzo Galanello
Journal:  Pediatr Rep       Date:  2011-06-16

3.  Secondary haemochromatosis in a patient with thalassemia intermedia.

Authors:  Ionela Rotaru; Amelia Gaman; G Gaman
Journal:  Curr Health Sci J       Date:  2013-12-29

Review 4.  Novel approach to reactive oxygen species in nontransfusion-dependent thalassemia.

Authors:  Paul I Tyan; Amr H Radwan; Assaad Eid; Anthony G Haddad; David Wehbe; Ali T Taher
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

5.  Transient Elastography (TE) is a Useful Tool for Assessing the Response of Liver Iron Chelation in Sickle Cell Disease Patients.

Authors:  Sophia Delicou; Konstantinos Maragkos; Maria Tambaki; Dimitrios Kountouras; John Koskinas
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-09-01       Impact factor: 2.576

6.  Thalassemia and hepatocellular carcinoma: links and risks.

Authors:  Maria Marsella; Paolo Ricchi
Journal:  J Blood Med       Date:  2019-09-17

Review 7.  Treating iron overload in patients with non-transfusion-dependent thalassemia.

Authors:  Ali T Taher; Vip Viprakasit; Khaled M Musallam; M Domenica Cappellini
Journal:  Am J Hematol       Date:  2013-03-08       Impact factor: 10.047

8.  Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.

Authors:  João Arezes; Niall Foy; Kirsty McHugh; Doris Quinkert; Susan Benard; Anagha Sawant; Joe N Frost; Andrew E Armitage; Sant-Rayn Pasricha; Pei Jin Lim; May S Tam; Edward Lavallie; Debra D Pittman; Orla Cunningham; Matthew Lambert; John E Murphy; Simon J Draper; Reema Jasuja; Hal Drakesmith
Journal:  Blood       Date:  2020-02-20       Impact factor: 25.476

Review 9.  When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.

Authors:  A T Taher; A Radwan; V Viprakasit
Journal:  Vox Sang       Date:  2014-10-07       Impact factor: 2.144

Review 10.  Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence.

Authors:  Alessandra Mangia; Davide Bellini; Umberto Cillo; Andrea Laghi; Giuseppe Pelle; Vanna Maria Valori; Eugenio Caturelli
Journal:  BMC Gastroenterol       Date:  2020-08-03       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.